Article ; Online: Identification of
2024 Volume 19, Issue 1, Page(s) 20220848
Abstract: Bortezomib (BTZ), a proteasome inhibitor, is a promising therapeutic option for multiple myeloma (MM) patients. However, drug resistance often occurs, leading to disease relapse and poor prognosis. In this study, we aimed to identify novel genes ... ...
Abstract | Bortezomib (BTZ), a proteasome inhibitor, is a promising therapeutic option for multiple myeloma (MM) patients. However, drug resistance often occurs, leading to disease relapse and poor prognosis. In this study, we aimed to identify novel genes associated with drug resistance and investigate their roles in BTZ resistance. Through the screening of 26 genes frequently associated with chemosensitivity or drug resistance, we discovered that KDM4C, a histone demethylase, exhibited increased expression in BTZ-resistant MM cells compared to their sensitive counterparts. Overexpression of |
---|---|
Language | English |
Publishing date | 2024-04-12 |
Publishing country | Poland |
Document type | Journal Article |
ZDB-ID | 2817958-4 |
ISSN | 2391-5412 ; 2391-5412 |
ISSN (online) | 2391-5412 |
ISSN | 2391-5412 |
DOI | 10.1515/biol-2022-0848 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.